Literature DB >> 26419279

D117N in Cypher/ZASP may not be a causative mutation for dilated cardiomyopathy and ventricular arrhythmias.

Aviva Levitas1, Yuval Konstantino2, Emad Muhammad3, Zaid Afawi4, Jean Marc Weinstein2, Guy Amit2, Yoram Etzion5,6,7, Ruti Parvari3,7.   

Abstract

Dilated cardiomyopathy (DCM) and malignant ventricular arrhythmias are important causes of congestive heart failure, heart transplantation, and sudden cardiac death in young patients. Cypher/ZASP is a cytoskeletal protein localized in the sarcomeric Z-line that has a pivotal role in maintaining adult cardiac structure and function. The putative mutation p.(D117N) in Cypher/ZASP has been suggested to cause systolic dysfunction, dilated left ventricle with hypertrabeculated myocardium, and intraventricular conduction disturbance, based on two reported sporadic cases. In two unrelated Bedouin families, one with pediatric DCM and the other with DCM and ventricular arrhythmias at young adulthood searching for the causative mutation by exome sequencing we identified the p.(D117N) variant in Cypher/ZASP. However, p.(D117N) did not segregate as the causative mutation in these families, i.e. it was not present in some patients and was found in several individuals who had no clinical manifestations. Furthermore, the carrier frequency in the Bedouin population of origin is estimated to be 5.2%, which is much higher than the incidence of idiopathic DCM in this population. Thus, our data support the notion that the p.(D117N) variant in Cypher/ZASP is not a causative mutation in the families tested by us. The results also indicates that at least in some cases, the p.(D117N) in Cypher/ZASP is not a causative mutation and the role of D117N in Cypher/ZASP in cardiac pathologies should be further clarified and re-evaluated.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26419279      PMCID: PMC4930098          DOI: 10.1038/ejhg.2015.195

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  14 in total

Review 1.  Non-invasive evaluation of arrhythmic risk in dilated cardiomyopathy: From imaging to electrocardiographic measures.

Authors:  Massimo Iacoviello; Francesco Monitillo
Journal:  World J Cardiol       Date:  2014-07-26

2.  Loss of function of hNav1.5 by a ZASP1 mutation associated with intraventricular conduction disturbances in left ventricular noncompaction.

Authors:  Yutao Xi; Tomohiko Ai; Enno De Lange; Zhaohui Li; Geru Wu; Luca Brunelli; W Buck Kyle; Isik Turker; Jie Cheng; Michael J Ackerman; Akinori Kimura; James N Weiss; Zhilin Qu; Jeffrey J Kim; Georgine Faulkner; Matteo Vatta
Journal:  Circ Arrhythm Electrophysiol       Date:  2012-08-28

Review 3.  Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms.

Authors:  N B Schiller; P M Shah; M Crawford; A DeMaria; R Devereux; H Feigenbaum; H Gutgesell; N Reichek; D Sahn; I Schnittger
Journal:  J Am Soc Echocardiogr       Date:  1989 Sep-Oct       Impact factor: 5.251

4.  Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies.

Authors:  P Richardson; W McKenna; M Bristow; B Maisch; B Mautner; J O'Connell; E Olsen; G Thiene; J Goodwin; I Gyarfas; I Martin; P Nordet
Journal:  Circulation       Date:  1996-03-01       Impact factor: 29.690

5.  Echocardiographic measurements in normal subjects from infancy to old age.

Authors:  W L Henry; J M Gardin; J H Ware
Journal:  Circulation       Date:  1980-11       Impact factor: 29.690

6.  Genetic analysis in patients with left ventricular noncompaction and evidence for genetic heterogeneity.

Authors:  Yanlin Xing; Fukiko Ichida; Taro Matsuoka; Takeshi Isobe; Yumiko Ikemoto; Takashi Higaki; Tohru Tsuji; Noriyuki Haneda; Atsushi Kuwabara; Rui Chen; Takeshi Futatani; Shinichi Tsubata; Sayaka Watanabe; Kazuhiro Watanabe; Keiichi Hirono; Keiichiro Uese; Toshio Miyawaki; Karla R Bowles; Neil E Bowles; Jeffrey A Towbin
Journal:  Mol Genet Metab       Date:  2006-01-19       Impact factor: 4.797

7.  Zasp/Cypher internal ZM-motif containing fragments are sufficient to co-localize with alpha-actinin--analysis of patient mutations.

Authors:  Tuula Klaavuniemi; Jari Ylänne
Journal:  Exp Cell Res       Date:  2006-02-14       Impact factor: 3.905

8.  Cardiac-specific ablation of Cypher leads to a severe form of dilated cardiomyopathy with premature death.

Authors:  Ming Zheng; Hongqiang Cheng; Xiaodong Li; Jianlin Zhang; Li Cui; Kunfu Ouyang; Liang Han; Ting Zhao; Yusu Gu; Nancy D Dalton; Marie-Louise Bang; Kirk L Peterson; Ju Chen
Journal:  Hum Mol Genet       Date:  2008-11-21       Impact factor: 6.150

9.  Ablation of Cypher, a PDZ-LIM domain Z-line protein, causes a severe form of congenital myopathy.

Authors:  Q Zhou; P H Chu; C Huang; C F Cheng; M E Martone; G Knoll; G D Shelton; S Evans; J Chen
Journal:  J Cell Biol       Date:  2001-11-05       Impact factor: 10.539

10.  ZASP interacts with the mechanosensing protein Ankrd2 and p53 in the signalling network of striated muscle.

Authors:  Valentina C Martinelli; W Buck Kyle; Snezana Kojic; Nicola Vitulo; Zhaohui Li; Anna Belgrano; Paolo Maiuri; Lawrence Banks; Matteo Vatta; Giorgio Valle; Georgine Faulkner
Journal:  PLoS One       Date:  2014-03-19       Impact factor: 3.240

View more
  3 in total

1.  Novel polymorphisms in PDLIM3 and PDLIM5 gene encoding Z-line proteins increase risk of idiopathic dilated cardiomyopathy.

Authors:  Dongfei Wang; Juan Fang; Jialan Lv; Zhicheng Pan; Xiang Yin; Hongqiang Cheng; Xiaogang Guo
Journal:  J Cell Mol Med       Date:  2019-08-19       Impact factor: 5.310

Review 2.  Cardiac Filaminopathies: Illuminating the Divergent Role of Filamin C Mutations in Human Cardiomyopathy.

Authors:  Matthias Eden; Norbert Frey
Journal:  J Clin Med       Date:  2021-02-04       Impact factor: 4.241

3.  Downregulation of Cypher induces apoptosis in cardiomyocytes via Akt/p38 MAPK signaling pathway.

Authors:  Tianming Xuan; Dongfei Wang; Jialan Lv; Zhicheng Pan; Juan Fang; Yin Xiang; Hongqiang Cheng; Xingxiang Wang; Xiaogang Guo
Journal:  Int J Med Sci       Date:  2020-08-27       Impact factor: 3.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.